1:15 pm Utilizing AI-Based Digital Pathology to Evaluate Denifanstat’s Anti-Fibrotic Effect in MASH Patients with Advanced Fibrosis
Time: 1:15 pm
day: Conference Day 1
Details:
- Reviewing denifanstat’s MOA and its robust anti-fibrotic effect in MASH patients with F3 fibrosis
- Applying digital pathology to assess the anti-fibrotic effect of denifanstat in MASH patients with advanced fibrosis
- Utilizing zonal analysis to explore denifanstat’s potential to offer long-term clinical benefit
